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Conformational Analysis of Environmental
Agents: Use of X-Ray Crystallographic Data
to Determine Molecular Reactivity
by Vivian Cody*
This paper explores the use of crystallographic techniques as an aid in understanding the molecular
reactivities of a number of agents that are of concern to pharmacologists and toxicologists. The selected
examples demonstrate the role of structural data in the determination of absolute configuration, config-
urational flexibility and active-site topology for a reactive species. For example, the role of absolute
stereochemistry in understanding synthetic pyrethroid structure-activity relationships is shown from
analysis oftheir crystal structures; conformational flexibility among DDT analogues, and the importance
ofconformational and electronic properties in phenylalkanoic acid herbicides are shown from systematic
analysis of their crystal structures; and interpretation of active-site stereochemistry is made by study of
computer modeling ofenzyme inhibitors in the active sites ofrelated protein crystal structures. Thus, the
observed patterns in conformational flexibility and their resultant effects on substrate pharmacological
profile can be interpreted in understanding the molecular level events that influence biological reactivity.
Introduction
Many strategies have been employed to understand
the molecular reactivities of small molecule substrates
acting at their target sites. The premise underlying the
development of structure-activity relationships is that
the correlations that exist between molecular structure
(or molecular shape) and observed biological responses
are the result of these substrates (hormones, drugs,
metabolites, agonists, antagonists, etc.) interacting with
their macromolecular target sites (receptors, enzymes,
bindingproteins, etc.). Thus, interactionwiththetarget
molecule not only depends upon substrate chemical con-
stitution, including such properties as charge, polarity,
and hydrophobic character, but also on the geometric
disposition ofkeymoieties. Therefore, a detailed knowl-
edge of molecular structure is fundamental to the un-
derstanding of structure-activity relationships.
An X-ray crystal structure determination provides a
detailed picture of the contents of a crystal lattice at
the atomic level and will uniquely define the three-di-
mensional conformation of a molecule from its atomic
positions. Provided one has a reasonably good quality
crystal, these parameters can provide an accurate de-
scription ofthe intramolecular geometry (bond lengths,
angles, and torsion angles to within ± 0.0003-0.005 A
and + 0.1-0.4°), and also describe intermolecular in-
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teractions such as hydrogen bonding and charge-trans-
fer between molecules. Moreover, the presence of
anomalously scatteringatomsinthe structure (e.g., hal-
ogens) willpermitthe absolute configuration ofallchiral
centers in the molecule to be defined. Also, data from
neutron diffraction experiments permit accurate loca-
tion of hydrogen atoms in the structure. Finally, high
resolution X-ray diffraction studies can describe the
electron density distribution within the bonding atoms
from charge-density studies.
Crystallographic observation ofthe substrate, target,
and target-substrate complex can provide the most re-
liabledescription ofthesemolecularinteractions, as well
as provide information concerning conformational pref-
erencesinflexiblemolecules. However, ingeneral, little
is known of the target site, and the stereochemical re-
quirements ofthe substrate-target interactions are often
poorlyunderstood. Forthis reason, target-sitetopology
has been deduced from comparisons of structural data
(solid state, solution, or isolated molecule) for a series
ofcompounds thatbind tothe target site and elicit vary-
ing degrees of activity.
However, to understand how substrate molecular
conformation caninfluence observedreactivity, itis nec-
essary to understand the factors that control confor-
mational properties. While there are a number ofterms
contributing to the total lattice energy in organic crys-
tals, only a few ofthese intermolecular forces are large
enough to influence molecular conformation. The prin-V. CODY
cipal terms considered in calculating the energetics of
conformational change include van der Waals forces,
hydrogen bonding, charge-transfer, and electrostatic
energies.
While the crystal structure ofa substrate will provide
information concerning its preferred conformation in a
particular environment, it provides no information con-
cerning the energy differences between conformations
and the energy barriers that separate them. Therefore,
by comparing the crystallographically observed confor-
mation with that (1) in solution, (2) in the free state, (3)
in different polymorphs, and (4) ofdifferent conformers
in the same crystal, the relative influence of these in-
termolecular forces on molecular conformation can be
investigated. Also, by analyzing the crystal structures
of a number of closely related molecules, one can look
for patterns in the consistency of their structural fea-
tures, and credence can be given to trends which may
not be statistically significant by themselves.
Thus, X-ray crystallographic techniques permit ac-
curate identification of the chemical constituents, defi-
nition ofthe absolute stereochemistry, and determination
of the range of conformational flexibility of substrate
molecules. Also, patterns in conformational flexibility
and theirresultant effects on substrate pharmacological
profile can be of importance in understanding the mo-
lecular level events that influence biological reactivity.
This paper will explore the use of crystallographic
techniques as an aid in understanding the molecular
reactivity of a number of systems that are of concern
to pharmacologists and toxicologists. In choosing these
examples, the aim is not to provide an exhaustive re-
view of the literature, but to illustrate, with selected
examples, the role of crystallographic data in the de-
termination of configuration, conformation, or active-
site topology of a reactive species.
Structure-Activity Relationships
Environmental Agents
Given in sufficient doses, most chemicals are toxic
poisons. Even the use of chemicals for their intended
purpose can lead to problems of contamination and dis-
posal. Also, a growing awareness and concern over the
use ofchemical agents that are eitherdeliberately (e.g.,
pesticides) or inadvertantly (e.g., pollutants) added to
the environment have led to renewed efforts to under-
stand their degradation and translocation in the envi-
ronment, aswell astheirmetabolism and effect on other
species.
The release into the atmosphere of polycyclic aro-
matic hydrocarbons that result from incomplete com-
bustion offossil fuels and vegetation has caused concern
since many of these environmental pollutants are car-
cinogenic. Also, the extensive use of halogenated aro-
matic compounds in many commercial products has made
their disposal an environmental hazard because oftheir
high chemical stability and lipophilicity which lead to
CH3
O)H3 H H3
H 0 H l
H 0
~~~H Rl
Rl
CH3
COCH3
R2
CH=CH2
CH3
CH2-CH3
H Natural asters OH3 OH
H 00 H
H H
Deltamethrin
* Asymmetric carbons
FIGURE 1. (a) Structures of natural pyrethrin esters and (b) potent
synthetic pyrethrin analog showing asymmetric carbons and
numbering.
long-term bioaccumulation (1,2). Pesticides are those
agents that are purposely, and often routinely, added
to the environment for the purpose ofkilling some form
of life; plant (herbicides) or animal (insecticides).
Pyrethroid Insecticides. Synthetic pyrethroid in-
secticides are photostable analogs of the naturally oc-
curring pyrethrin esters (Fig. 1) and have low mammilian
toxicity, short persistenceinthe environment, and elicit
rapid insect paralysis (3). The most potent pyrethrine
analogs can have eight possible isomers formed by com-
binations of configurations about the three asymmetric
carbons in the structure (Fig. lb). Structure-function
data show that the most active pyrethroid compounds
are cyclopropane carboxylic acid esterswith two methyl
groups on C-2 and an unsaturated side chain on C-3
which is oriented cis to the ester group (Fig. 1) in syn-
thetic pyrethroids and trans in the natural esters (3).
Substitution of these groups results in a great loss of
activity. These characteristics suggest the importance
of molecular shape in activity. X-ray crystallographic
analyses were carried out to determine reliable struc-
tural information concerning absolute stereochemistry,
molecular dimensions, and conformation (4-7).
The absolute configuration of the most potent insec-
ticide (Fig. 2a) in this series is (a.S) cis (1R,3R), as
determined fromits crystal structure (5). The structural
data for three other analogs (5-7) show that although
the molecule is flexible (Fig. 2), there are regions with
conformational similarities. All the structures were re-
solved into their optical antiopods except that ofFigure
2c, which crystallized as aracemic mixture and is shown
as the ((xS) tranis (1S,3R) isomer.
In this series, the conformational influence of two
substituents-benzylic cyano and vinyl halogens-were
studied. Those structures without the cyano group are
less active and, because their crystal structures are iso-
morphous (Fig. 2b,d), there are no conformational dif-
ferences. When there is no a-cyano substitution, and
thus alossofachiralcenter, the esteroxygeniscoplanar
with the phenyl ring, while in the two cyano compounds
the ester bond is nearly perpendicular. In addition, the
two cyano anlaogs have different stereochemistries at
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FIGURE 2. Crystallographic conformations of four synthetic pyrethrin analogs: (a) oa-cyano cis-3-(2,2-dlibromovinyl) analog (5); (b) cis-3-(2,2-
dibromovlnyl) analog (6); (c) (lR,trans)-3-(2,2-dichlorovinyl) analog (7); (d) cis-3-(2,2-dichlorovinyl) analog (6).
C-1. The conformation of the diphenyl ether moiety in
these structures is either twist or antiskewed (8,9), as
defined by the torsion angles about the ether oxygen.
The net effect ofthese different diphenyl ether confor-
mations is to change the overall shape ofthe molecule.
In the structure without the cyano substituent, the di-
phenyl ether conformation is twist and the outer phenyl
ring folds back toward the gem dimethyl of the cyclo-
propyl ring (Fig. 2b,d). In the active isomer (Fig. 2a),
the diphenyl ether conformation is twist and the mol-
ecule is more extended. The racemic structure (Figure
2c) has the opposite chiral stereochemistry at C-1 from
that of Figure 2a, and further has an antiskewed di-
phenyl ether conformation. This places the vinyl chlor-
ine atoms toward the center of the inner ring.
Preferred conformations computed by theoretical cal-
culations (10) were carried out for these pyrethroids
and show that the minimum energy conformation cor-
responds to that observed in the crystal structure. These
calculations alsoindicatethatthereisrestrictedrotation
ofthe vinylgroup, resultingin apreferred conformation
that is also observed in solution (10) and in the crystal
structure (Fig. 2d). Although these calculations show
no preferred conformation for rotation about the alpha
carbon, the extended form is observed both in solution
and in the crystal structure.
Therefore, these structural studies have delineated
the absolute configuration about the critical chiral cen-
ters and have shed light on the conformational influence
of active group substitution to the overall molecular
shape. These dataare alsoconsistentwith solution stud-
ies (10) showing that the proximity of the cyano and
ester groups is important for activity.
Organochlorine Insecticides. The organochlorine
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FIGURE 3. Organochlorine insecticide classes which all act as neuropoisons, although their mechanisms of action are presumed at different
sites.
insecticides include the chlorinated ethane derivatives
ofwhich DDT is the best known example. Other classes
include the cyclodienes such as chlordane, aldrin, and
endrin, which are chloromethano-bridged cyclic carbon
compounds; the hexachlorocyclohexanes such as lin-
dane; and the fused chlorocyclopentanes such as mirex
and kepone (Fig. 3). While all of these classes act as
neuropoisons, their mechanism or site of action is not
yet clearly understood (1).
Toxicological studies indicate that DDT alters the
transport ofNa+ and K+ ions across the membranes of
nerve axons by producing a repetitive discharge of the
insect nervous system. Its mechanism ofaction is thought
toinvolve astereospecific fitinto nerve membrane-pore
channels and the formation of charge-transfer com-
plexes with constituents in the nerve fibers (11-13). In
this general receptor model, a constraint is placed upon
the conformation ofthe two phenyl rings such that their
symmetrical dipoles are sterically fixed relative to the
trihalomethyl bridging group. This fixes the two phenyl
rings in a"butterfly" conformation, e.g., withbothrings
perpendicular to the plane of the bridging atoms.
These structure-activity data show that several fea-
tures of the DDT molecule are important to its insec-
ticidal properties. For example, substitutions larger than
chlorine on the bridge ethane C-1 atom produce inactive
analogues; chlorination ofthebridge head carbonresults
in a twisted diphenyl ring conformation and loss of ac-
tivity; and an ethylene bridging unit causes loss in ac-
tivity, presumably because the bridge angle opens to
1200 and changes the orientation ofthep,p'-chloro groups
(12). Therefore, the important conformational features
for active DDT analogs include (1) the rotation of the
phenyl rings about the bridge atom, (2) the nature of
the bridge substituent, and (3) the nature and position
of the phenyl ring substituents.
To investigate the molecular mechanism of DDT ac-
tion, the crystal structures of several active DDT an-
alogs were undertaken (13-21). As illustrated (Figs. 4
and 5), the overall conformation of the diphenyl rings
is variable but similar to the proposed model. Since
these molecules crystallize in centrosymmetric space
groups, there are two mirror-image conformations pos-
sible. The absolute configuration has been determined
foronly one DDT analog; (-) o,p'-DDT (15), and all other
structures have been made consistent with this enan-
tiomorph for the purpose of comparison.
The proposed active DDT conformation has two phenyl
rings open and facing each other (e.g., butterfly) with
the bridging torsion parameters near 900 for both an-
gles. These structural studies show (Fig. 5) that, while
there is a broad range of values observed for these
parameters, they all fall within the same quadrant of
conformational space. The most toxic analogs are clus-
tered close together (e.g., Nos. 1-4), while those that
are moderately active (e.g., Nos. 7,13-15) are more
broadly grouped. This group also includes the active
halogen-free analogs (Nos. 13,14). The inactive analogs
Kepone
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FIGURE 4. Molecular conformation of DDT analogs: (a) p,p'-DDT (14) with van der Waals surface, highly active; (b) (-) o,p'-DDT (15) with
van der Waals surface, highly active; (c) p,p'-DDE (17) with van der Waals surface, inactive; (d) overlap of (c) and the dichloromethyl
analog (17) (dashed surface) illustrating the larger volume of the active analog; (e) overlap of (a) and (c); (f) overlap of (c) and (d). The
conformational parameters of these compounds are points 1, 2, 8, and 10 of Fig. 5, respectively.
(Nos. 8,9,11,12) are located at the extremes ofthis con-
formational space. As illustrated (Fig. 6), there is a
large conformational difference between active 2,2-di-
chloromethyl analog (No. 10) and its inactive dichloro-
ethylene analog (Nos. 8,9). The bridging angle in the
ethylene structure is 1180 and 1090 in the methyl com-
pound, and there is a difference in the volume occupied
by these bridging groups that appears to be important
foractivity. A similardifference is noted forthe inactive
acid metabolite, p,p'-DDA (Nos. 11,12) which also oc-
cupies a smaller volume and has electronic properties
similar to those of the ethylene compound. The impor-
tance ofthese properties is further reflected inthe mod-
erate activity ofthe propyl bridge analog (No. 13), which
is halogen-free.
These studies have defined the molecular size and
shape necessary to elicit insecticidal activity and have
shown that, as the aromatic character of the bridging
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FIGURE 5. Plot of DDT halomethyl bridge torsion angles as defined
in the diagram (13-21).
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FIGURE 6. Crystallographic conformations of organochlorine insecticides: (a) aldrin (23); (b) isodrin (24); (c) endrin (23); (d) dieldrin (25),
illustrating their endo-exo configurations and oxo formation; (e-g) show the overlap of these respective structures. The distance between
the electronegative centers are also illustrated.
unit increases (e.g., Figs. 4c,d), its toxicity decreases.
Furthermore, these data showthat anisostructuralunit
of size similar to that of the trichlormethyl group can
function tostericallyfixtheconformationofthediphenyl
rings and that chloro substitution of the bridge is not
necessary.
The chlorinated cyclodienes (Fig. 3) are wide-spec-
trum insecticides produced by a Diels-Alder reaction
between the cyclic diene, hexachlorocyclopentadiene,
and an olefin. The insecticidal activity of the resulting
adducts depends on the nature and complexity of the
dienophile and its substituents. Structure-activity data
illustrate that the geometrical patterns of these com-
pounds have an important bearing on their insecticidal
properties (22). These data further suggest that the
structural features required for optimal insecticidal ac-
tivity include the presence of two electronegative cen-
ters positioned within a narrow range of distance and
direction from each other and with a specific orientation
with respect to the dichloromethano bridge of the cy-
clodiene compound. It has been shown that the cyclo-
diene epoxides are metabolically active; thus those
compounds that do not form epoxides have little or no
toxicity (22).
To understand the stereochemical nature ofthese in-
secticides, crystal structure analyses ofthe most active
cyclodienes have been investigated (22-28). The most
toxic compounds are a family of hexachlorodimethano-
a)
C
d)
Endrin
----2.s3A
9)
Dieldrin
Endrin
h)
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FIGURE 7. van der Waals surface for endrin (23) viewed (a) parallel to the distance shown in Fig. 6, and (b) perpendicular to this line.
naphthalenes, e.g., aldrin (Fig. 3). While there are four
different geometric configurations possible for these
compounds, structural data show that only two isomers
are observed: endo-exo aldrin (23) and endo-endoisodrin
(24) and endrin (23) (Fig. 6).*
The importance of molecular shape in relation to in-
secticidal activity is illustrated by the comparison of
endo-exo-(O)exo dieldrin (25) with its endo-endo-(O)exo
isomer, endrin (24) (Fig. 6), which has lower toxicity
(22). This indicates that the spatial orientation of the
electronegative oxygenin dieldrinis criticalfortoxicity.
The overall shape of dieldrin is cylindrical with the
chlorines describing the maximum circumference ofthe
cylinder. Dieldrin is more elongated than its endo-endo
isomer endrin (Fig. 7). The distance between the two
electronegative centers (midpoint ofthe double bond to
the midpoint of the C-C bond of the oxo ring) is also
shown for these molecules (Fig. 6). These data suggest
that the active site recognizes only a narrow range of
values for these compounds.
Another family of active dienes, the hexachlorome-
thanoindenes, e.g., heptachlor (Fig. 3), show increased
toxicity with addition of a chlorine in the 1-position.
The structure ofthe heptachlor (27) and its epoxide (28)
have been carried out and show the epoxide is exo, an
important configuration forthe hightoxicity ofthis class
of compounds (22).
Therefore, these structural studies have confirmed
the stereochemical assignment ofthe active cyclodienes
and show that the relative orientation of the electro-
negative groups is critical for their insecticidal activity.
Herbicides. The halogenated phenoxyalkanoic acids
selectively kill broad-leafed plants by stimulating ex-
cessive and disorganized growth, thus acting as auxins
or plant hormone herbicides (1). These compounds also
*A feature ofthe Diels-Alder reaction involves the stereochemical
orientation ofthe addends. These additions favor the orientation which
has the diene double bonds close to the unsaturated substitutents of
the dienophile and is designated endo (inside). Thus, the substituent
is directed to the convex side ofthe resulting cyclohexene ring. Con-
versely, exo (outside) has the substituent directed to the concave side
of the ring.
demonstrate molecular engineering techniques by tak-
ing advantage ofspecies metabolic differences to create
species selective herbicides. The most potent herbicides
in this class are 2,4-dichlorophenoxyacetic acid (2,4-D),
2,3,5-trichlorophenoxyacetic acid (2,4,5-T), and 4-chloro-
2-methylphenoxyacetic acid (MCPA) (Fig. 8). The cor-
responding 2-methyl-2-phenoxypropionic acids are in-
active as herbicides, but do possess antilipolytic and
antihypocholesterolemic activity (1).
Structure-activity data indicate stringent stereospe-
cific requirements forrecognition by a receptor in order
to elicit herbicidal activity (29,30). Phenoxyalkanoic acids
with only phenyl ring substituents at either the 2,4, or
5 position (or in all of them) are active, whereas sym-
metrically substituted phenyl ring compounds are not.
Also, those chlorophenyl analogs with a methyl at the
acetic acid C-1 position are active, but not those with a
dimethyl substitution. The influence ofphenyl ring sub-
stitution and side chain substitution is reflected by the
activity and inactivity ofthe pairs ofcompoundsp-chlo-
rophenylacetic acid (No. 5, Fig. 8) and phenylacetic acid
(No. 1) and 2,4-D (No. 6) and its 2,2-dimethyl side chain
analog (No. 7). These data also show that an ether link
is essential for auxin activity and that when there is an
asymmetric carbon in the side chain, the D-isomers are
more potent than the L isomers (29,30). Based on these
structure-activity relationships, a three-point contact
receptormodel was proposed whichrequired the proper
orientation ofthe acid side chain carboxyl group, the oa-
hydrogen and phenyl ring with appropriate electrone-
gative characteristics (29,30).
Crystallographic analyses of phenoxyalkanoic acids
were carried out to determine the conformational prop-
erties of this class of compounds and to elucidate the
specific stereochemical features that could explain their
herbicidal activity (31,32). These data show striking
conformational similarities among these structures and
indicate that there is a distortion of the exo-C-1 acetic
acid bond angles and also ofthe central atom ofthe acid
function (31). In addition, the ether bond angle is near
1180, and the bridging bond distances reflect the influ-
ence oftheir aromatic and alkyl substitutions. As illus-
trated (Fig. 9), the conformation of the active analogs
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can be planar (2,4,5-T) or, as in 2,4,5-TP, the carboxy
function is perpendicular to the plane ofthe rest of the
molecule. The inactive analog 2,4,6-T has the sidechain
perpendicular to the phenyl ring. However, in the in-
active 2-methyl analog, the acid function is nonplanar,
as observed for 2,4,5-TP.
Conformational energy calculations have not been
carried out, but free rotation about the ether-acetate
bond is expected. Calculations ofthe charge-density dis-
tribution within these compounds could show differ-
ences that might indicate why symmetrically substituted
phenyl ring compounds are inactive.
Polyhalogenated Aromatic Hydrocarbons. The
halogenated aromatic hydrocarbons most prevalent in
the environment arethepolychlorinated (PCB) orbrom-
inated (PBB) biphenyls (Fig. 10) whose lipophilic prop-
erties lead to their accumulation in many tissues.
However, one of the most toxic is 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (dioxin), a trace by-product in the syn-
thesis of 2,4,5-T (1,2). There are 75 possible chlorine
substituted dioxin isomers and their toxicity depends
upon both the number and position of the halogens.
Since a number of these halogenated aromatic hydro-
carbons are formed as trace contaminants in the syn-
thesis of several commercial products, structure-activity
relationships have been derived in order to understand
thier mechanisms of bioactivity (33-40).
A number ofPCBs and dioxin analogs have been used
as model compounds to investigate the specific struc-
tural requirements for cytosol receptor binding and for
induction ofaryl hydrocarbon hydroxylase activity (33-
37). X-ray crystallographic analyses also have been car-
ried out to elucidate their conformational properties (38-
42). As illustrated (Fig. 10), many of these compounds
have common structural features.
Toxicological studies have further demonstrated that
the most toxic PCBs and PBBs are those that have
halogens in both the meta and para positions of both
rings, but no ortho substituents (40). Crystallographic
analysis of these biphenyls show that the most stable
conformation is nonplanar, with the dihedral angle be-
tween the phenyl rings of470 (39) (Fig. 11). Analysis of
these compounds usingmolecularorbitaltechniques (43)
shows that the minimum energy conformation of struc-
tures without ortho substituents is 420, while it is 900
forortho-substituted compounds, in agreement with the
crystallographic results. However, activity data for the
dioxin or naphthyl compounds indicate that a planar
conformation is required for toxicity. Therefore, inter-
pretation of these data suggests that the minimum re-
quirements for toxicity include four halogens positioned
laterally on the biphenyl rings, and a planar
conformation.
However, more recent quantitative structure-activ-
ity data (37) indicate that molecular shape and polar-
izability are important factors in determining molecular
reactivity and that hydrophobic, hydrogen bonding and
electronic forces play a critical role in determining these
properties. These data further suggest that halogen
substitution in both phenyl rings is not a requirement
for binding, nor is a planar structure. The molecular
shape and thickness ofthese compounds will be affected
by the conformation about the biphenyl bond and by
the buttressing effects ofadjacent halogens on the phenyl
rings.
The results ofthese studies suggest that a model for
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FIGURE 9. Crystal structures ofphenylalkanoic acid insecticides (31.32), illustrating conformations observed for active and inactive analogs.
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toxic structures requires fourlateralchlorines arranged
in a box ofapproximate area 3 x 1oA, or ifbrominated,
three lateral bromines arranged in a triangle (40) (Fig.
10). This area defines the surface of the smallest en-
velope that a planar molecule may occupy and elicit its
toxic response at its target site.
Polycyclic Aromatic Hydrocarbons. Many of the
polycyclic aromatic hydrocarbons (PAH) that are car-
cinogenic are derived from a benzo[a]anthracene skel-
eton (Fig. 12). Structure-activity data show that the
carcinogenic properties of this large class of PAHs are
highly stereospecific and depend upon their chemical
structure (1,44,45). It was also noted that most carcin-
ogenic PAHs contain an angular three-ringed phenan-
thracene unit and that the greatest chemical reactivity
is associated with the 5-6bond, called the Kregion (Fig.
12). Thus, the earliest structure-activity profiles re-
lated the electronic structure of these compounds to
theircarcinogenicity (45). Recent datanow suggest that
their carcinogenic action is related to their metabolism
involving arene oxides, dihydrodiols and diol epoxide
formation (Fig. 12b).
Although a large number of polycyclic aromatic hy-
drocarbon metabolites have been identified, especially
those of benzo[a]pyrene (BP), the ultimate carcinogen
is believed to be an epoxide dihydrodiol formed by the
action ofmixed function oxygenase enzymes. These en-
zymes can produce two diastereoisomeric diol epoxides,
designed by the disposition ofthe epoxide function with
respect to the hydroxy group. Thus, the syn isomer has
the epoxide and hydroxy on the same side of the ring,
while the anti has them on opposite sides. These data
FIGURE 13. Crystal structure of 7,12-dimethyl-5,6-epoxy
benzo(a)pyrene (52) viewed (a) perpendicular to the pyrene ring
system and (b) parallel to the ring system, illustrating the bay
region crowding and distortion of the rings.
show that the mutagenic and carcinogenic properties of
these isomers differ greatly. The anti isomer has been
identified as the ultimate carcinogen (45), while the syn
isomerismoremutagenic. Additionally, Kregionoxides
and diol epoxides have been shown to bind covalently
to nucleic acids (44-47).
Crystallographic studies of many of the more potent
carcinogenic PAHs have been carried out and show im-
portant conformational differences whencomparedwith
their non carcinogenic parent hydrocarbons (46,47).
ManyofthePAHs areplanar, whereastheirmethylated
derivatives are nonplanar due to the steric interactions
of the methyl hydrogens with those of the polycyclic
ring hydrogens, particularly in the crowded Bay region
of the molecule (Fig. 13). This is the case for the most
potent carcinogenic PAHs, 7,12-dimethylanthracene
(DMBA) and 5-methylchrysene.
More recent structural data have investigated the
stereochemistry ofBP diol epoxides using naphthalene
derivatives as model compounds (48-52). These data
reveal that in the structure ofthe 2-methyl BP analog,
3,4-epoxy-2-methyl-1,2,3,4-tetrahydro-1-naphthol, the
hydroxy and epoxide oxygens are syn and there is an
internal hydrogen bond between them that persists in
solution (48). Inthe structure ofthe anti3,4-dihydroxy-
1,2,3,4-tetrahydronaphthalene-1,2-oxide isomer (51), the
two hydroxy groups are equatorial, as observed in the
BP epoxide (52). The epoxide oxygen does not partici-
pate in any hydrogen bonding as observed in the syn
2-methyl analog (48).
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The stabilities of these epoxy diol BP analogs have
been computed using quantum mechanical methods (53)
which show that the cis axial-axial diol epoxide is the
more reactive species; however, no intramolecular hy-
drogen bond was indicated. More recent data using mo-
lecular shape analysis of polycyclic aromatic
hydrocarbons indicate that the quantitative structure-
O COOH a) CH2 0KCH_CFL2' ~COOH
H,_CH2 2 H
NH2 < H Folic Acid
NH2
C) C OCH3
NH2 OCH3
OCH3
Trimethoprim
d) NH2
NH H3
DAMP
FIGURE 14. Substrates and inhibitors ofdihydrofolate reductase: (a)
folic acid, natural substrate; (b) methotrexate, species-nonspecific
reductase inhibitor; (c) trimethoprim, bacterial reductase inhibi-
tor; (d) DAMP, mammalian reductase inhibitor.
(a) (b)
activity relationships derived can be used to estimate
the mutagenic potency without explicit consideration of
metabolic activation pathways (54).
Thus, these studies have led to definitive information
concerning specific structural parameters ofimportance
for the mutagenic and carcinogenic characteristics of
these compounds. While these data have helped shape
the concepts ofcarcinogenicity, there stillremains much
tobelearned about howthese stereospecific interactions
signal their molecular reactivity.
Pharmacological Agents
In contrast to the toxic properties associated with
environmental agents, pharmacological or therapeutic
agents are biologically active compounds which, when
applied appropriately, modify physiological systems for
the benefit of the recipient. Since many pharmacologi-
cally important drugs act by inhibiting enzymes, kinetic
studies of their inhibitory effects provide valuable in-
formation on their potency and mechanisms of action.
Therefore, studies ofdrug (or hormone) action are con-
cerned with understanding the relationships observed
between drug structure and biological activity, and de-
veloping a receptor theory to account for these
observations.
The receptor can be characterized by describing the
properties of compounds that react with it, thus pro-
ducing a "negative replica" of the receptor from the
composite ofthe structure-activity information assem-
bled. Compounds that combine with the receptor and
produce a change in cellular properties are agonists,
while those that combine with it, but do not elicit the
given responses are antagonists. Understanding these
(C)
FIGURE 15. Profile view ofthe antineoplastic DHFR inhibitors showing the "bowing" caused by the pyrimidine ring distortions (58): (a) DAMP
(55); (b) DAEP; (c) DAPP.
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dataare notstraight forward since there are manytypes
of competition that can arise with the interaction of a
drug with its receptor site.
NH2
a) 1.350
1.341 R
N3 /
1.351
NH2 N
R
NH2
b) 1.336
1. R
1.3
NH2 1.349N 1.366 R
K, - (7) H- (8)
FIGURE 16. Comparison ofthe average diaminopyrimidine nitrogen
geometry observed from their crystal structures (56) for (a) un-
protonated and (b) Ni protonated structures. The figures in pa-
rentheses refertothenumberofstructuresincludedintheaverages.
Although there are several examples of pharmaco-
logically important agents that have been studied crys-
tallographically, only dihydrofolate reductase inhibitors
and thyroid hormone analogs will be examined in detail.
Steroid hormone structures are described in another
paper in this issue.
Dihydrofolate Reductase Inhibitors. The enzyme
dihydrofolate reductase (DHFR), a necessary compo-
nent for all cell growth, is strongly and specifically in-
hibited by certain substrate analogs with binding
affinities so great that they are not readily displaced by
the natural folic acid substrates (Fig. 14). It has been
shown that the general requirement for tight binding
of inhibitors to DHFR from any species is a 2,4-dia-
minopyrimidine ring structure (55). Also, the binding
IODOTHYRONINE DEIODINATION
7I
T4
rrT3 T"
Il
3,5-T2 3,31-T2
3-T1
Iodine
( Nitrogen
Oxygen
FIGURE 17. Iodothyronine deiodination pathway ofthe thyroid hormone thyroxine (T4) to the hormonally active(T:) metabolites and hormonally
inactive (rTi3) metabolites.
III
4,
174
/,n 1, ItCONFORMATIONAL ANALYSIS OF ENVIRONMENTAL AGENTS
a)
b)
Iodine
* Nitrogen
Oxygen
c)
FIGURE 18. Molecular structures ofthyroid hormones with a (a) skewed diphenyl conformation (T4) (66) and (b) antiskewed rT3 (67); (c) the
stereo overlap of the skewed (...) and antiskewed conformations.
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selectivity and specificity of inhibitors for DHFR from
different species can vary significantly with only a single
substituent change.
Comparison ofseveral lipophilic 5-substituted analogs
show that those with a 5-adamantyl substituent are the
most effective inhibitors ofmammalian DHFR and pos-
sess significant antineoplastic activity (56). For exam-
ple, there is a 500-fold increase in inhibitory potency
within this series of 5-adamantyl-6-substituted antifol-
ates with 6-H < propyl < methyl < ethyl. In order to
investigate the conformational aspects of binding spec-
ificity to DHFR, crystallographic analyses were carried
out on this series and their results compared with the
structural data from other antifolate classes (57-63).
These datarevealthatthe moststrikingfeature ofthese
adamantyl antifolates is their "bowed" shape (Fig. 15),
caused by the steric crowding of the 5-adamantyl and
the 4- and 6-substituents. This interference forces the
pyrimidine ring to be significantly distorted from plan-
arity. These data further demonstrate the effects ofNi
protonation of the pyrimidine ring geometry. Compar-
ison of the endocyclic bonds at C2 (Fig. 16) indicates
thatprotonation causes the N1-C2 bond to lengthen and
the C2-N3 bond to decrease (58). To investigate the
significance of these structural changes to the binding
energies and basicity ofthese compounds, CNDO/2 mo-
lecular orbital calculations were carried out (64) and
were able to reproduce the pyrimidine ring torsional
distortions observed in their crystal structures, as well
as the geometry changes upon protonation at Ni. The
rotational energy barrier was also computed and showed
that the minimum energy conformation was the same
as observed in the crystal structure. However, these
calculations were not able to accurately reproduce the
exocylcic amino geometry and this discrepancy can af-
fect the charge density distributions within the pyrim-
idine ring.
Pyrimidine antifolates with a 5-benzyl substituent,
such astrimethoprim (TMP) (Fig. 14), havethe greatest
selectivity in their binding for bacterial DHFR. Struc-
tural studies of TMP (59,60) show that it can adopt
several equi-energy conformations. Structure-activity
data show that those TMP compounds with a function-
alized 4'-substituent are more potent than TMP itself.
Analysis ofthe 4'-isopropenyl and 4'-carbomethoxy de-
rivatives (59) shows that these substituents are per-
pendicular to the benzyl plane and, unlike TMP, place
density both above and below the ring plane.
Structural studies have also been carried out on the
natural substrate folic acid (63) and show that the over-
all molecular shape is similar to that of the inhibitor
methotrexate as observed in the protein structures of
DHFR frombacterial sources (65). Quantummechanical
and dynamic energy calculations have also been carried
out on the folate molecules (66,67), and these results
show that there is considerable flexibility in the orien-
tation of the side chains and that the low energy con-
formation corresponds to that found in the crystal
structures.
As a result of these studies the geometries of these
compounds have been accurately defined, as have their
hydrogen bondingpatterns and conformational and elec-
tronic properties. These observations may explain their
antifolate characteristics and provide a means for the
rational design of more selective antifolates.
Thyroid Hormone Structures. Thyroid hormones
(Fig. 17) are secreted from the thyroid gland into the
general circulation where they are bound to one of sev-
eral serum proteins. These hormones are also the only
halogenated molecules that are biologically active, and
have a number of specific proteins and enzymes that
transport and metabolize them. Therefore, it is of in-
terest to speculate on the role that these thyroid pro-
teins and enzymes may have in the concentration and
transport of other halogenated species. As observed,
many of the most toxic environmental agents are hal-
ogen-containing compounds. Therefore, the possibility
exists that these compounds could be recognized by these
thyroid hormone specific proteins.
Structural studies carried out on the thyroid hor-
mones and their analogs (68) have shown that these
molecules are flexible and that each of the hormone-
specific binding proteins requires a different confor-
mation for maximal binding affinity. The specific stereo-
chemical properties ofthe thyroid hormones arise from
the steric influence ofthediortlho innerringiodines upon
the diphenyl ether conformation. Minimal steric inter-
action between the 3,5-iodines and the outer ring 2',6'-
hydrogens is maintained when the conformation is
skewed (e.g., the two rings are mutually perpendicular
and bisecting). Because ofthe restricted rotation about
the ether bridge, the crystal structures of all diortho-
substituted thyroactive analogs have a skewed confor-
mation (68), while that of3',5',3-triiodothyronine, (rT:)
(69) is antiskewed (Fig. 18).
Conformational analysis of the crystallographic data
permits the delineation ofcharacteristic patterns within
these structures that can be correlated with their hor-
mone action. These data showthat there exist preferred
orientations of hydrogen bonds and iodine intermolec-
ular contacts that can indicate spatial preferences for
critical functional groups within the binding environ-
ment ofa hormone responsive protein or enzyme (9,70).
Ofparticular interest in the mechanism by which the
thyroid hormones are deiodinated (Fig. 17). The most
active form ofthe hormone, 3,5,3'-triiodothyronine (T;),
is derived from the deiodination of thyroxine (T,) in
peripheral tissues. The enzyme iodothyronine deiodi-
nase produces either metabolically active (T:) or inac-
tive (rT) products (Fig. 17). Structure activity studies
of the inhibition of this enzyme (70-72) by a variety of
compounds including radiographic contrast agents, dyes,
and flavones indicate that the enzymes recognition pro-
cess is under stereospecific control involving stringent
requirements for maximal inhibition. Many of these in-
hibitors are of concern since their ingestion can inter-
rupt normal thyroid function and lead to physiological
problems. Such is the case with the radiographic con-
trast agents which have slow rates of metabolic clear-
ance and have been shown to cause hypothyroidism by
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FIGURE 19. Flavone classes.
inhibition of the deiodination pathway (73).
Flavones are ubiquitous natural products (Fig. 19)
derived from plant pigments. Aurones are the most po-
tent inhibitors of iodothyronine deiodinase (74). In an
effort to identify structural features common to natural
substrates and inhibitors ofthe deiodinase enzyme, three
conformational models of the most potent aurone, au-
reusidin, were compared with the observed crystal
structures of the thyroid hormones (Fig. 20) (75). The
skewed conformation is not a permitted aureusidin con-
formation since it requires rotation about the bridging
double bond. This, on the other hand, is the confor-
mation observed for all hormonally active thyroid com-
pounds (68). A planar structure is also an energetically
favorable aurone conformation, but not one that can be
adopted by the thyroid compounds. Finally, the anti
skewed conformation has been observed in the crystal
structure of rT3, a natural inhibitor of deiodinase, and
is alikely aurone conformation. Thus, these studies sug-
gest that the deiodinase enzyme can bind a substrate
or inhibitor in either the skewed or antiskewed
conformation.
Receptor Models
Since crystal structures ofthe protein-substrate com-
plex have been determined for dihydrofolate reductase
and prealbumin, many previously proposed hypotheses
concerning the structural basis for binding and activity
of the antifolate and thyroid hormones can be tested.
The results of the crystal structure determination of
DHFR from four species, complexed with the cofactor
NADPH and with inhibitors (65,76), provide specific
informationconcerning thebackbone conformation, spa-
tial arrangement of the side chains, and a general de-
scription of the inhibitor binding site.
Computer graphic modeling of the fit of various in-
hibitors in the active site of DHFRs has been under-
taken. Lipophilic antifolate binding to chicken liver
FIGURE 20. Aureucidin conformational models: (a) planar; (b) anti-
skewed; (c) skewed; and (d) stereo overlap of all three.
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FIGURE 21. Binding models of (a) 1-naphthyldiaminopyrimidine (55) in the active site of chicken liver DHFR (76), showing the poor fit of the
naphthyl ring in the binding pocket; (b) 2-naphthyldiaminopyrimidine in the same site which shows no steric interference. The stippling is
the protein surface.
(a) (b)
FIGURE 22. Binding models of (a) DAEP in the active site of chicken liver DHFR; (b) with the ethyl side chain rotated 1100 and fit into an
alternate binding pocket.
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(a)
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FIGURE 23. Stereo diagrams of (a) the thyroxine binding site in the crystal structure of prealbumin (77); (b) of the binding of aureucidin in
an antiskewed conformation with its phenyl ring matched to the outer ring of thyroxine of prealbumin. (The van der Waals surface of
aureucidin is also shown);
DHFR was modeled by positioning the diaminopyrim-
idine ring in the same orientation as observed struc-
turally for the diaminopteridine ring of methotrexate
(57). This orientation was also verified from crystallo-
graphic studies of the binary complex of chicken liver
DHFR and DAMP (Matthews, personal communica-
tion). These observations showed that there is no steric
crowding of the adamantyl ring in the binding cavity.
However, when the structure of the 5-(1-naph-
thyl)diaminopyrimidine, a noncompetitive inhibitor (57),
was modeled in the same manner, the outer portion of
the naphthyl ring penetrates through the surface ofthe
binding pocket and comes into close contact (< 1.3 A)
with a phenylalanine residue (Fig. 21a). Even when the
naphthyl ring is rotated, there is no satisfactory ori-
entationforthering. Ontheotherhand, whenthe active
2-naphthyl analog is similarly modeled, there are no
unfavorable interactions (Fig. 21b). More subtle fea-
tures of the inhibitor-substrate interactions are ob-
served when the binding of the 6-ethyl adamantyl
structure is compared with that of the less active 6-
methyl analog. Figure 22a focuses on the 6-ethyl posi-
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(C)
(d)
FIGURE 23. (c) The binding ofdioxin (42) with its chlorophenyl ring matched to the outer phenyl ring of thyroxine in the prealbumin binding
site (The van der Waals surface of dioxin is also shown.); (d) DDT (14) with its p-chlorophenyl ring matched to the inner ring ofthyroxine
in the prealbumin binding site.
tion of the antifolate structure as observed from its
crystal structure (58), while Figure 22b shows that a
1100 rotation of the ethyl sidechain places the outer
carbon in an alternate binding pocket that appears to
be more suitable. This observation would suggest that
the ethyl analog is more active because of the added
hydrophobic interactions with the enzyme and that there
is not sufficient room to fit the propyl sidechain in this
pocket, hence its lesser activity.
Similar observations have been made for the binding
interactions of the thyroid hormones with the serum
protein prealbumin (77). Prealbuminiscomposed offour
identical subunits that form a channel running through
the length ofits structure, forming the thyroxine bind-
ing site. These structural data also provide a detailed
environment fortheiodine atoms ofthe hormone as well
as a quantitative description of the iodine interactions
in the active site (Fig. 23a). Iodothyronine analogs that
are potent inhibitors of iodothyronine deiodinase are
also strong binders to thyroxine-binding prealbumin.
Because ofthis similarity, the thyroxine binding site in
the crystal structure ofprealbumin was used as amodel
for the active site of iodothyronine deiodinase. As il-
lustrated (Figs. 23b and c) both the planar and anti-
180CONFORMATIONAL ANALYSIS OF ENVIRONMENTAL AGENTS
skewed models for aureucidin are able to fit into the
thyroxinebindingsiteofprealbumin, suggestingamode
of inhibitor recognition. This model helps explain the
iodothyronine analog inhibition data and suggests that
more specific enzyme inhibitors can be designed.
Since the halogenated pollutants such as dioxin, DDT
or the phenylalkanoic acid insecticides may bind to the
thyroid hormone specific proteins in much the same
manner as the thyroid hormones, models of their bind-
ing to the active site in prealbumin were also studied.
As shown (Fig. 23), these compounds can fit into the
thyroxine binding site and position at least one oftheir
chlorines in aniodine bindingpocket. Thesetoxic agents
can be accommodated in the binding site with their ring
structures matched to either the inner or outer phenyl
ring of thyroxine. While these models show that these
pollutants canfit intothebindingchannel ofprealbumin,
the data for the deiodinase inhibitors suggest that not
all of the inhibitor structure need overlap the thyroid
hormone to elicit enzyme recognition. Therefore, these
studies indicate the type of possible interactions that
may be operative in the concentration of these pollu-
tants by the thyroid hormone proteins.*
Summary
This paper has described the role of X-ray crystal-
lographic data in delineating those structural charac-
teristics that are relevant for enhanced active-site
binding and function among a series of environmental
and pharmacological agents. These examples show how
structural data were used to define absolute configu-
ration, molecular shape, conformational flexibility and
active-site topology.
For example, structural analysis ofthe synthetic pyr-
ethyroid insecticides has defined the absolute stereo-
chemistry of the three chiral centers in the molecule
and demonstrate the importance ofconformation to the
stereoselectivity of these compounds. The presence of
a cis or trans configuration of the functional groups
attached to the cyclopropane ring has a dramatic influ-
ence on the overall shape of the molecule with the
(S)cis(1R,3R) configuration being required for maximal
activity.
Within the series of DDT analogs, analysis of the
diphenyl ring conformation indicates that there is a nar-
row range of values permitted for the most toxic com-
pounds. These data further show that the overall shape
of the molecule is important and that there is a steric
size and aromatic character prerequisite for the bridg-
ing groups to elicit maximal toxicity.
Structural analysis of the phenylalkanoic acid herbi-
cides indicates that factors other than molecular con-
formation dominate the structure-activity relationships
since the active and inactive analogs can have the same
conformation. These data, however, do suggest that the
charge-density properties of these compounds are of
importance to activity. Thus, the availability ofaccurate
geometrical parameters for this series of compounds is
a necessary starting point for these calculations.
Similarly, structural analysis ofthe lipophilic antifol-
ates has shown that adamantyl substitution causes dis-
tortion of the pyrimidine ring planarity by steric
crowding with adjacent ring substituents. This results
in an overall "bowed" shape to the molecule and could
explain the enhanced antineoplastic activity ofthis fam-
ily of compounds compared with other antifolates with
similar lipophilicities. Furthermore, the crystal struc-
ture determination of DHFR from several species has
permitted observation of the active site and modeling
ofthe binding ofother antifolates within it. These stud-
ies have defined the conformational space available for
binding and have delineated the important interactions
of the inhibitor-enzyme binding complex and have fur-
ther permitted the rational design of other inhibitors.
Perhaps most importantly, this type of structural
study now permits a more realistic interpretation of
structure-activity relationships of systems where no
specific structural data are yet available. For example,
use of structural data from a related family of proteins
to model the inhibitor-enzyme complex permits a more
precise description of the types ofinteractions that are
important. This approach is demonstrated in the inter-
pretation ofthe structure-activity relationships among
flavones as potent inhibitors ofthe enzyme iodothyron-
ine deiodinase. By using the thyroxine binding site of
prealbumin as a model, correlations were observed that
could help explain the mode of action of these com-
pounds. In a similar manner, this site was also used to
explore the possible binding modes accessible to the
halogenated environmental agents such as dioxin and
DDT and in this way show a mode of entry of these
species into tissues.
The future will see a greater emphasis on the input
of specific and well-determined structural data, and as
more protein structures and enzymes become available
from solid state and solution, the "negative replica" of
the receptor will develop into a clear "picture" of the
active site mechanism of action of these important
systems.
The author thanks Catherine DeVine, Danielle Smith and Yi-Yan
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and for the literature searches; Melda Tugac, Gloria DelBel, and Queen
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*Recent workers have provided experimental evidence for their
modeling predictions that chlorinated dibenzodioxins and dibenzofur-
ans can be effective competitive binding ligands for thyroxine binding
sites in prealbumin (78).
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